Gynther, M., Estrada, M. L., Loppi, S., Korhonen, P., Kanninen, K. M., Malm, T., . . . Puris, E. (2022). Increased expression and activity of brain cortical cPLA2 due to chronic lipopolysaccharide administration in mouse model of familial Alzheimer’s disease. Pharmaceutics, 14(11), . https://doi.org/10.3390/pharmaceutics14112438
Chicago Style (17th ed.) CitationGynther, Mikko, et al. "Increased Expression and Activity of Brain Cortical CPLA2 Due to Chronic Lipopolysaccharide Administration in Mouse Model of Familial Alzheimer’s Disease." Pharmaceutics 14, no. 11 (2022). https://doi.org/10.3390/pharmaceutics14112438.
MLA (9th ed.) CitationGynther, Mikko, et al. "Increased Expression and Activity of Brain Cortical CPLA2 Due to Chronic Lipopolysaccharide Administration in Mouse Model of Familial Alzheimer’s Disease." Pharmaceutics, vol. 14, no. 11, 2022, https://doi.org/10.3390/pharmaceutics14112438.